Skip to content
MedsAcross

Medicine

Zolpidem 12.5 mg extended-release tablet

Zolpidem · Oral
Available on requestPrescription onlyUS FDAControlled, schedule CIVGeneric name

Zolpidem 12.5 mg extended-release tablet is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).

Key facts

Active ingredient (INN)
Zolpidem
Brand
Sold under the generic name
Strength
12.5 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 55 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaLupinIndiaBryant Ranch PrepackProficient RxAphena Pharma Solutions - TennesseeSandozAsclemedBreckenridge Pharmaceutical12 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIV
ATC code
N05CF02 Zolpidem
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
6 December 2010
Identifiers
RxCUI 854880, 854894DailyMed set ID c3f23bc3-595b-28e5-e053-2a95a90a9c2c, 25e71199-c55d-4cc6-8388-b309d654d2b0, 08411424-e8a8-4964-bd04-5b0b5aa5baaf +17NDC 72189-230, 63187-114, 71610-730 +17Application ANDA078970, ANDA090107, ANDA213592 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 12 labelers. The register lists 58 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, extended release in 1 bottle68180-780-04LupinIndia21 May 2024
500 tablet, film coated, extended release in 1 bottle47335-308-13Sun Pharmaceutical IndustriesIndia15 May 2017
100 tablet, film coated, extended release in 1 bottle47335-308-88Sun Pharmaceutical IndustriesIndia15 May 2017
100 tablet, extended release in 1 bottle51991-982-01Breckenridge Pharmaceutical18 May 2026
100 tablet, extended release in 1 bottle0781-5316-01Sandoz31 October 2011
500 tablet, extended release in 1 bottle0781-5316-05Sandoz31 October 2011
30 tablet, extended release in 1 bottle0781-5316-31Sandoz31 October 2011
30 tablet, extended release in 1 bottle63629-4597-1Bryant Ranch Prepack29 August 2012
60 tablet, extended release in 1 bottle63629-4597-2Bryant Ranch Prepack16 November 2015
28 tablet, extended release in 1 bottle63629-4597-3Bryant Ranch Prepack5 September 2024
8 tablet, extended release in 1 bottle63629-4597-4Bryant Ranch Prepack5 September 2024
18 tablet, extended release in 1 bottle63629-4597-5Bryant Ranch Prepack5 September 2024
90 tablet, extended release in 1 bottle63629-4597-6Bryant Ranch Prepack5 September 2024
30 tablet, extended release in 1 bottle71335-1180-1Bryant Ranch Prepack4 April 2019
60 tablet, extended release in 1 bottle71335-1180-2Bryant Ranch Prepack9 July 2024
28 tablet, extended release in 1 bottle71335-1180-3Bryant Ranch Prepack9 July 2024
8 tablet, extended release in 1 bottle71335-1180-4Bryant Ranch Prepack9 July 2024
18 tablet, extended release in 1 bottle71335-1180-5Bryant Ranch Prepack9 July 2024
90 tablet, extended release in 1 bottle71335-1180-6Bryant Ranch Prepack9 July 2024
30 tablet, film coated, extended release in 1 bottle71335-1468-1Bryant Ranch Prepack9 January 2020
60 tablet, film coated, extended release in 1 bottle71335-1468-2Bryant Ranch Prepack12 May 2022
28 tablet, film coated, extended release in 1 bottle71335-1468-3Bryant Ranch Prepack12 May 2022
8 tablet, film coated, extended release in 1 bottle71335-1468-4Bryant Ranch Prepack12 May 2022
18 tablet, film coated, extended release in 1 bottle71335-1468-5Bryant Ranch Prepack12 May 2022
90 tablet, film coated, extended release in 1 bottle71335-1468-6Bryant Ranch Prepack12 October 2020
120 tablet, film coated, extended release in 1 bottle71335-1468-7Bryant Ranch Prepack12 October 2020
100 tablet, film coated, extended release in 1 bottle72162-2441-1Bryant Ranch Prepack15 January 2025
30 tablet, film coated, extended release in 1 bottle72162-2441-3Bryant Ranch Prepack15 January 2025
30 tablet, extended release in 1 bottle63187-114-30Proficient Rx1 January 2019
15 tablet, film coated, extended release in 1 bottle63187-862-15Proficient Rx1 June 2017
30 tablet, film coated, extended release in 1 bottle63187-862-30Proficient Rx1 June 2017
60 tablet, film coated, extended release in 1 bottle63187-862-60Proficient Rx1 June 2017
90 tablet, film coated, extended release in 1 bottle63187-862-90Proficient Rx1 June 2017
30 tablet, extended release in 1 bottle71205-286-30Proficient Rx21 June 2019
60 tablet, extended release in 1 bottle71205-286-60Proficient Rx21 June 2019
90 tablet, extended release in 1 bottle71205-286-90Proficient Rx21 June 2019
30 tablet, film coated, extended release in 1 bottle71610-254-30Aphena Pharma Solutions - Tennessee22 March 2019
28 tablet, extended release in 1 bottle71610-730-28Aphena Pharma Solutions - Tennessee12 April 2024
30 tablet, extended release in 1 bottle71610-730-30Aphena Pharma Solutions - Tennessee30 August 2023
100 tablet, extended release in 1 bottle76420-319-01Asclemed11 April 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 16 December 1992Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Zolpidem

Clinical summary

Zolpidem is a gamma-aminobutyric acid A receptor positive modulator indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. It is available as tablets, extended-release tablets and sublingual tablets for oral use. MedsAcross supplies Zolpidem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Zolpidem

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Zolpidem 12.5 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.